Patent · US Active

Inhibitors of Bruton's tyrosine kinase

US10189817B2 · kind B2 · utility

0Cited by

10References

6Claims

0Family size

Assignee

Biogen MA Inc. · US

Inventors

Brian T. Hopkins · Newton, US
Xiongwei Cai · Arlington, US
Timothy Chan · Cambridge, US
Patrick R. Conlon · Wakefield, US
Michael Humora · Weston, US
Tracy J. Jenkins · Watertown, US
J. Michael Macphee · Cambridge, US
Xianglin Shi · Newton, US
Ross A. Miller · Fanwood, US
Andrew Thompson

Key dates

Filing date	Jan 19, 2018
Grant date	Jan 29, 2019
Priority date	—
Expiry date	Jan 19, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides a compound, solid forms, and compositions thereof, which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same. The present invention also provides methods of making provided compound and solid forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.